In the media 13 Sep 2020Weak research funding hampers Africa Covid-19 clinical trialsAfrica Science News
Press releases 4 Sep 2020Innovative single-dose oral sleeping sickness treatment to be co-developed by Sanofi and DNDi partnership
Press Releases Translations 4 Sep 2020Sanofi et DNDi vont développer un médicament unidose innovant, par voie orale, pour le traitement de la maladie du sommeil
In the media 1 Sep 2020Recibe financiación un proyecto en Granada que busca tratamientos contra enfermedades tropicalesEuropa Press
Scientific articles 25 Aug 2020Hit-to-lead optimization of a benzene sulfonamide series for potential antileishmanial agentsRSC Medicinal Chemistry
In the media 20 Aug 2020Ascletis completed bridging study of ASC18, a one-pill, once-a-day complete HCV oral regimenAP News
Scientific articles 19 Aug 2020Animal models of Chagas disease and their translational value to drug developmentExpert Opinion on Drug Discovery
Scientific articles 17 Aug 2020Fixed vs adjusted-dose benznidazole for adults with chronic Chagas disease without cardiomyopathy: A systematic review and meta-analysisPLOS Neglected Tropical Diseases
Scientific articles 11 Aug 2020Characterizing the non-linear pharmacokinetics of miltefosine in paediatric visceral leishmaniasis patients from Eastern AfricaJournal of Antimicrobial Chemotherapy
In the media 5 Aug 2020Early preparedness, intensive response key to combating COVID-19MIMS Infectious Diseases
In the media 4 Aug 2020The Malaysian response to COVID-19: Building preparedness for ‘surge capacity’, testing efficiency and containmentEuropean Pharmaceutical Review
Statements 15 Oct 2018DNDi North America submits brief to the Canadian Standing Committee on Health (HESA) Study on Federally Funded Health Research
Statements 10 Sep 2018DNDi contribution to the World Health Organization roadmap on access to medicines and vaccines 2019-2023
Statements 24 May 2018DNDi and MMV, supported by Unitaid, deliver statement about R&D and access to child-friendly medicines at the 71st World Health Assembly
Statements 27 Jan 2018Medicines for Malaria Venture and DNDi deliver statement on R&D for children-friendly medicines at WHO EB142
Statements 21 Sep 2016DNDi Welcomes the Political Declaration of the United Nations High-Level Meeting on Antimicrobial Resistance
Statements 14 Sep 2016DNDi response to the Report of the United Nations Secretary-General’s High-Level Panel on Access to Medicines
Statements 27 May 2016DNDi delivers statement about CEWG on R&D Financing and Coordination at 69th World Health Assembly
